Abstract:Subsequently to the publication of the above article, the authors have realized that an error was introduced in the preparation of Fig. 2B for publication. In Fig. 2B, the lanes shown for the western blot were misannotated. Additionally, in the legend of Fig. 2C, '24 h post‑infection' should have been written as '12 h post‑infection'. Furthermore, the description of the data shown in Fig. 2B in the Results section (sentence commencing on p. 1635, the subsection 'HTNV activates caspase‑1 and pro‑IL‑1β in THP‑1 cells', line 10), was incomplete. The sentence here should have read as follows (the added text is highlighted in bold): 'In order to investigate whether caspase‑1 was activated during HTNV infection, the culture supernatant of HTNV‑infected THP‑1 was ultra‑ﬁltered and an increased concentration of secreted caspase‑1 was detected post‑infection compared with the Mock group; similar results were also observed in the LPS‑ and ATP‑stimulated groups (Fig. 2B)'. The correct version of Fig. 2, with the lanes of the western blot in Fig. 2B labelled correctly and the appropriate changes having been made to the Figure legend, is shown opposite. The errors associated with this Figure did not have an impact on the overall meaning of the paper, or on the reported conclusions of this study. The authors regret that this Figure was not corrected prior to the publication of this article, and apologize to the readership for any inconvenience caused. [the original article was published in International Journal of Molecular Medicine 35: 1633‑1640, 2015; DOI: 10.3892/ijmm.2015.2162].

Author Correction: STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation

Corrigendum: NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Author Correction: Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets

Author Correction: Denervation-activated STAT3–IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis

Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Correction: Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of T H 17 cells and T reg cells

Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Correction: Caveolin-1-mediated STAT3 Activation Determines Electrotaxis of Human Lung Cancer Cells

Corrigendum: Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro

Author Correction: Structural insights into the activation of metabotropic glutamate receptors

[Corrigendum] NLRP3 inflammasome is responsible for Hantavirus inducing interleukin‑1β in THP‑1 cells

Author Correction: STEEP mediates STING ER exit and activation of signaling

Correction: A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis

Corrigendum: A Synthetic Small Molecule F240B Decreases NLRP3 Inflammasome Activation by Autophagy Induction

Zanin et al. Analysis of Radiation Toxicity in Mammalian Cells Stably Transduced with Mitochondrial Stat3. Int. J. Mol. Sci. 2023, 24, 8232

Correction to: The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression

Erratum to “miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1β Pathway to Meliorate Neuropathic Pain”

Publisher Correction: The transcriptional cofactor Tle3 reciprocally controls effector and central memory CD8 + T cell fates